載入...
Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
OBJECTIVES: Mobility impairments constitute a long-term burden in patients with multiple sclerosis (MS). Currently there is evidence that the drug fampridine may improve nonwalking symptoms in MS patients. The main objective of this study is to analyze whether participants showing a beneficial walki...
Na minha lista:
| 發表在: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475844/ https://ncbi.nlm.nih.gov/pubmed/31037211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319835136 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|